SMAD7 and glioblastoma: Disitertide is a TGF-β inhibitor peptide, which can decrease proliferation, migration, invasiveness, and tumorigenicity in GBM cells in vitro by a reduction in SMAD2 phosphorylation, the downregulation of SKI and the upregulation of SMAD7 [32].